Cyclin-dependent kinase inhibitors: novel anticancer agents.
about
p42/p44 MAPKs are intracellular targets of the CDK inhibitor purvalanol.Design, synthesis, and antiproliferative and CDK2-cyclin a inhibitory activity of novel flavopiridol analogues.Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.The best of both worlds - managing the cancer, saving the bone.Effects of an Indolocarbazole-Derived CDK4 Inhibitor on Breast Cancer CellsConstitutive CCND1/CDK2 activity substitutes for p53 loss, or MYC or oncogenic RAS expression in the transformation of human mammary epithelial cellsH-RN, a peptide derived from hepatocyte growth factor, inhibits corneal neovascularization by inducing endothelial apoptosis and arresting the cell cycle.UCN-01 induces S and G2/M cell cycle arrest through the p53/p21(waf1) or CHK2/CDC25C pathways and can suppress invasion in human hepatoma cell lines.Targeting the cell cycle for cancer therapy.Cyclin G1 and cyclin G2 are expressed in the periimplantation mouse uterus in a cell-specific and progesterone-dependent manner: evidence for aberrant regulation with Hoxa-10 deficiency.Myeloid cell leukemia-1 is associated with tumor progression by inhibiting apoptosis and enhancing angiogenesis in colorectal cancer.Activation of JNK/c-Jun is required for the proliferation, survival, and angiogenesis induced by EET in pulmonary artery endothelial cells.Effect of cis-9, trans-11-conjugated linoleic acid on cell cycle of gastric adenocarcinoma cell line (SGC-7901).The in vitro activity of the tyrosine kinase inhibitor STI571 in BCR-ABL positive chronic myeloid leukaemia cells: synergistic interactions with anti-leukaemic agents.Euphorbia mauritanica and Kedrostis hirtella extracts can induce anti-proliferative activities in lung cancer cells.Sox2 targets cyclinE, p27 and survivin to regulate androgen-independent human prostate cancer cell proliferation and apoptosis.Cyclin-dependent kinase inhibitor SU9516 enhances sensitivity to methotrexate in human T-cell leukemia Jurkat cells.Intracellular Targets of Paullones. Identification following affinity purification on immobilized inhibitor.Stat6 cooperates with Sp1 in controlling breast cancer cell proliferation by modulating the expression of p21(Cip1/WAF1) and p27 (Kip1).Oligosaccharides from human milk induce growth arrest via G2/M by influencing growth-related cell cycle genes in intestinal epithelial cells.
P2860
Q30847612-795F39E0-CF06-4CF9-8795-8F0D1E338AE6Q33264498-98327B03-1584-41F0-BB64-D04BDCB83A89Q33586833-4798FAF5-019A-4F8A-BCE0-EC82AC640641Q33705252-BD251743-4C7F-4F60-A572-79E52411B435Q33920055-B638345C-2238-45CB-8091-835E90C207F3Q34487091-7AB253DC-97ED-41DE-B889-109F0D580222Q34579889-01B8B2A4-263A-4AB2-B73C-1BA55072744CQ34596341-B83C8AA9-83DD-402F-8DA2-45B4B95AD2CDQ34640744-C748A26E-123C-4481-BC69-1863E30A53F7Q34728354-BF3BC8A1-9B06-4B00-A30C-606DA2F69344Q34763271-A0A77F5E-190F-4392-AA66-6D6312716894Q34991284-E78F045D-0E4C-432E-A4ED-3D41CC309AB2Q35958442-32B9C16B-F4C3-4DD8-B5C4-E71CF6855AD5Q36316043-CDDDA728-29AE-418B-8348-5F3FB862D1BCQ38283303-0E0F0E00-A767-4DE5-BD97-267625621838Q39255529-A3122D59-42A9-4A76-80DD-875B16C0D846Q39370686-22FC25E7-B98D-43E1-B135-F4D01897DC44Q43199246-870EAE15-D606-45F8-9D81-85C4311006D0Q43966314-9C27A206-57F0-4550-9EEA-5F4B6A8539B3Q51755890-C4150A2F-DCB4-41F4-A0F8-6A2E26B75000Q53431329-1599982F-B07F-4169-91F5-BC5046E473C9
P2860
Cyclin-dependent kinase inhibitors: novel anticancer agents.
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@ast
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@en
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@nl
type
label
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@ast
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@en
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@nl
prefLabel
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@ast
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@en
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@nl
P2093
P2860
P1476
Cyclin-dependent kinase inhibitors: novel anticancer agents.
@en
P2093
P2860
P304
P356
10.1517/13543784.9.8.1849
P407
P577
2000-08-01T00:00:00Z